Skip to Main Content

Author Details

Russell T Burke
Knight Cancer Institute, Oregon Health & Science University
2010
12
10
PMIDPaper TitleJournal TitlePublished Year
35868306Integrative analysis of drug response and clinical outcome in acute myeloid leukemia.Cancer Cell2022
30333627Functional genomic landscape of acute myeloid leukaemia.Nature2018
30037299Loss of p53 expression in cancer cells alters cell cycle response after inhibition of exportin-1 but does not prevent cell death.Cell Cycle2018
28467801Inhibition of exportin-1 function results in rapid cell cycle-associated DNA damage in cancer cells.Oncotarget2017
27213923Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics.J Vis Exp2016
25895498YM155 potently kills acute lymphoblastic leukemia cells through activation of the DNA damage pathway.J Hematol Oncol2015
26399741Longitudinal tracking of single live cancer cells to understand cell cycle effects of the nuclear export inhibitor, selinexor.Sci Rep2015
24659719A potential therapeutic strategy for chronic lymphocytic leukemia by combining Idelalisib and GS-9973, a novel spleen tyrosine kinase (Syk) inhibitor.Oncotarget2014
23220742The selective SYK inhibitor P505-15 (PRT062607) inhibits B cell signaling and function in vitro and in vivo and augments the activity of fludarabine in chronic lymphocytic leukemia.J Pharmacol Exp Ther2013
23900138CX-4945, a selective inhibitor of casein kinase-2 (CK2), exhibits anti-tumor activity in hematologic malignancies including enhanced activity in chronic lymphocytic leukemia when combined with fludarabine and inhibitors of the B-cell receptor pathway.Leukemia2013
20018656Identification of MIR390a precursor processing-defective mutants in Arabidopsis by direct genome sequencing.Proc Natl Acad Sci U S A2010
20562854Unique functionality of 22-nt miRNAs in triggering RDR6-dependent siRNA biogenesis from target transcripts in Arabidopsis.Nat Struct Mol Biol2010
  • 1 - 12 of 12

Recommended Authors

Peter S Winter
Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School
Career Start Year 2014
Number of shared co-authors 0
Andrew Goodspeed
University of Colorado Denver | Anschutz Medical Campus
Career Start Year 2013
Number of shared co-authors 1
Amanda L Christie
Dana-Farber Cancer Institute
Career Start Year 2010
Number of shared co-authors 2
Frederick S Vizeacoumar
College of Medicine, University of Saskatchewan
Career Start Year 2010
Number of shared co-authors 0
Stuart J Blakemore
Center for Molecular Medicine Cologne (CMMC), University of Cologne
Career Start Year 2010
Number of shared co-authors 2
Anagha Deshpande
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 2009
Number of shared co-authors 0
Jordi Carreras Puigvert
Department of Pharmaceutical Biosciences, Uppsala University
Career Start Year 2009
Number of shared co-authors 0
Jarkko Ylanko
Sunnybrook Research Institute
Career Start Year 2007
Number of shared co-authors 0
Alexandre Puissant
Universite de Paris, INSERM, CNRS
Career Start Year 2007
Number of shared co-authors 1
Kris C Wood
Duke University
Career Start Year 2005
Number of shared co-authors 0
Anna M Eiring
Texas Tech University Health Sciences Center at El Paso
Career Start Year 2004
Number of shared co-authors 10
Justin Cidado
Oncology R&D
Career Start Year 2003
Number of shared co-authors 4
Xiaohu Zhang
National Center for Advancing Translational Sciences
Career Start Year 2003
Number of shared co-authors 0
Elena Ivanova
Dana-Farber Cancer Institute
Career Start Year 2003
Number of shared co-authors 0
John Connelly
Institute of Genetics and Cancer, University of Edinburgh
Career Start Year 2000
Number of shared co-authors 0
Eddy S Yang
University of Alabama at Birmingham, O'Neal Comprehensive Cancer Center
Career Start Year 1999
Number of shared co-authors 0
Rose Hurren
Princess Margaret Cancer Centre
Career Start Year 1999
Number of shared co-authors 2
Nhu-An Pham
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1998
Number of shared co-authors 0
Mathew J Garnett
Wellcome Sanger Institute
Career Start Year 1998
Number of shared co-authors 3
Changchun Deng
Center for Lymphoid Malignancies, Columbia University Medical Center
Career Start Year 1997
Number of shared co-authors 0
Kimberly Stegmaier
Dana-Farber Cancer Institute
Career Start Year 1995
Number of shared co-authors 4
Krister Wennerberg
University of Copenhagen
Career Start Year 1994
Number of shared co-authors 6
Ricky W Johnstone
The University of Melbourne
Career Start Year 1990
Number of shared co-authors 3
Todd R Golub
Broad Institute of MIT and Harvard
Career Start Year 1989
Number of shared co-authors 5
Aaron D Schimmer
Princess Margaret Cancer Centre
Career Start Year 1989
Number of shared co-authors 4
Charles M Rudin
Memorial Sloan Kettering Cancer Center
Career Start Year 1989
Number of shared co-authors 0
Lori S Hart
Children's Hospital of Philadelphia, USA. [2] Center for Childhood Cancer Research
Career Start Year 1987
Number of shared co-authors 0
Richard B Lock
Children's Cancer Institute, Lowy Cancer Research Centre, School of Clinical Medicine
Career Start Year 1987
Number of shared co-authors 2
Charles L Sawyers
Memorial Sloan Kettering Cancer Center
Career Start Year 1986
Number of shared co-authors 3
Scott H Kaufmann
Mayo Clinic
Career Start Year 1977
Number of shared co-authors 7

Collaborators

Brian J Druker
Oregon Health & Science University
Co-authored papers 6
Marc M Loriaux
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 6
Stephen E Spurgeon
Knight Cancer Institute, Oregon Health and Science University
Co-authored papers 5
Jeffrey W Tyner
Oregon Health & Science University School of Medicine
Co-authored papers 5
Bill H Chang
Oregon Health and Science University
Co-authored papers 3
Jade Bryant
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 3
Kara Johnson
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 3
Nicola Long
Oregon Health and Science University
Co-authored papers 2
Michael W Deininger
University of Utah Huntsman Cancer Institute
Co-authored papers 2
Amy Yates
Co-authored papers 2
Uma Borate
The Ohio State University
Co-authored papers 2
Rachel R Pallapati
Clinical Research Services, University of Miami Sylvester Comprehensive Cancer Center
Co-authored papers 2
Daniel A Pollyea
University of Colorado Division of Hematology
Co-authored papers 2
Anupriya Agarwal
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 2
Kim-Hien T Dao
Astex Pharmaceuticals
Co-authored papers 2
Cristina E Tognon
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 2
Amanda d'Almeida
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 2
Haijiao Zhang
Oregon Health & Science University, Knight Cancer Institute
Co-authored papers 2
Elie Traer
Oregon Health & Science University
Co-authored papers 2
David Tyler Sweeney
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 2
Andy Kaempf
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 2
James Dibb
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 2
Aashis Thapa
Emory School of Medicine
Co-authored papers 2
Pierrette Lo
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 2
Jessica Leonard
Oregon Health & Science University
Co-authored papers 2
Aurora S Blucher
Knight Cancer Institute, Oregon Health Sciences University
Co-authored papers 2
Melissa L Abel
National Cancer Institute, National Institutes of Health
Co-authored papers 2
Justin M Watts
University of Miami, Sylvester Comprehensive Cancer Center
Co-authored papers 2
Joelle Wolf
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 2
Cody Coblentz
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 2
Release 1.2